No Data
No Data
Chengzhi Co., Ltd. (000990.SZ): D-ribose can be used as a starting ingredient for certain COVID-19 drugs
Gelonghui May 13 丨 Some investors asked Chengzhi Co., Ltd. (000990.SZ) on the investor interactive platform, “Can the company's products be used for COVID-19 drugs?” The company replied that the company's D-ribose can be used as a starting ingredient for certain COVID-19 drugs.
Chengzhi Co., Ltd.'s (SZSE:000990) Business And Shares Still Trailing The Industry
You may think that with a price-to-sales (or "P/S") ratio of 0.9x Chengzhi Co., Ltd. (SZSE:000990) is a stock worth checking out, seeing as almost half of all the Chemicals companies in China have P/S
Chengzhi Co., Ltd. (000990.SZ): The synthetic biology business is one of the company's main businesses in the biomedical sector
Gelonghui, May 9 | Chengzhi Co., Ltd. (000990.SZ) said on the investor interactive platform that the synthetic biology business is one of the company's main businesses in the biomedical sector. Among them, production and sales of the company's D-ribose series products have grown rapidly in recent years. Currently, they dominate the global market and are widely used in medicine, nutrition and health care, food and beverage, clinical nutrition, etc. D-mannose developed by the company was mass-produced in 2023, and product sales have been growing steadily.
Chengzhi Co., Ltd. (000990.SZ): A new enzyme independently developed using synthetic biology technology has completed strain construction and the development of a new process for enzyme conversion, and is currently undergoing testing
Gelonghui, May 9 | Chengzhi Co., Ltd. (000990.SZ) said on the investor interactive platform that the company has independently developed a new enzyme using synthetic biology technology that has completed strain construction and the development of a new process for enzyme conversion. It is currently undergoing testing and certification, and has applied for a number of patents. In 2023, the company cooperated with Academician Tan Tianwei's team to establish the “Chengzhi Co., Ltd. - Beijing University of Chemical Technology Joint Engineering Research and Transformation Center” to carry out in-depth cooperation in strain construction and enzyme modification, process optimization and technology iteration, incubation of innovative achievements, etc., to continuously enrich product categories and promote the company's high-quality development. The future, the company
Chengzhi (SZSE:000990) Has A Rock Solid Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how
Chengzhi Co., Ltd. (000990.SZ): Overseas business is mainly TFT LCD products, D-ribose and other products
Gelonghui, April 18, 丨 Chengzhi Co., Ltd. (000990.SZ) held a performance briefing on April 17, 2024. Regarding “Can you talk about the development of the company's overseas business, the intensification of domestic competition, and whether overseas business expansion will increase”, the company replied that the company's overseas business is mainly products such as TFT LCD products and D-ribose, and the market sales of these products are good. In the future, dynamic adjustments will be made according to domestic and foreign market conditions.
No Data